Lymphoma

Lymphoma
2025-06-03T00:00:00.000+10:00
Ongoing

BGB-11417-303

BGB-11417-303
Lymphoma

A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Trial overview

Clinical Area

Haematology

Disease

Lymphoma

Disease site

Malignant Haematology

Study Phase

III

Trial Identifiers

Registration number: NCT06943872

https://clinicaltrials.gov/study/NCT06943872

GenesisCare Location(s)
Principal Investigator(s)
Haematologist

Dr David Kliman

MBBS (Hons), FRACP, FRCPA

Dr David Kliman
location pin icon

North Shore

View Profile
Profile Image - Dr David Kliman

Clinical trials enquiries

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.